Greystar buys Greenford site for giant PRS scheme
Greystar Europe Holdings has bought, with an institutional partner, the 26.5 acre site former GlaxoSmithKline site in Greenford, West London for a major purpose built rental housing led scheme.
The site, formerly home to the GlaxoSmithKline and J. Lyons & Co. operations, will comprise mixed use development with a significant focus on rental housing but also including for-sale residential, employment, active retail, amenity, and community uses.
Greystar said that upon completion it will be the largest purpose built rental housing development created in the UK.
The development is part of Greystar’s plans to introduce its multifamily proposition to the UK market.
Greystar is the largest multifamily operator in the US and a large operator of student housing in the UK, and manages over 410,000 residences worldwide.
For entire article, click View More below.
The site, formerly home to the GlaxoSmithKline and J. Lyons & Co. operations, will comprise mixed use development with a significant focus on rental housing but also including for-sale residential, employment, active retail, amenity, and community uses.
Greystar said that upon completion it will be the largest purpose built rental housing development created in the UK.
The development is part of Greystar’s plans to introduce its multifamily proposition to the UK market.
Greystar is the largest multifamily operator in the US and a large operator of student housing in the UK, and manages over 410,000 residences worldwide.
For entire article, click View More below.
Media Resources
View our PRESS KITPress Release Archives
-
Greystar acquires new site in London subject to planning
-
Greystar announces €725m close for flagship pan-European closed-end value-add residential strategy
-
Greystar Closes on Remaining 55% Interest in Thackeray Partners
-
Greystar Joins Leading CEOs in Unprecedented Commitment to Advance Diversity and Inclusion in the Workplace
-
Greystar Wins 2020 PERE Global Awards in Three Categories